Refreshing results…
ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer
UploadEndogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
Download from doi.orgMissing publications? Search for publications with a matching author name.